Gibson Christopher 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2021/12/9 申報
- 申報編號
- 0001209191-21-068922
- 申報時間
- 2021/12/9
- 交易日
- 2021/11/21-12/7
- 申報延遲
- 18 天遲報
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 7 筆非衍生性交易。公開市場賣出合計 $40.5 萬。交易後 18 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gibson ChristopherCIK 0001856369 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/21 | Class B Common Stock | G贈與處分 | −1,100,000 | $0.00 | $0 | 8,217,883 | 直接 | |
| 2021/11/21 | Class B Common Stock | G贈與取得 | +550,000 | $0.00 | $0 | 550,000 | 間接 | |
| 2021/11/21 | Class B Common Stock | G贈與取得 | +550,000 | $0.00 | $0 | 550,000 | 間接 | |
| 2021/12/7 | Class B Common Stock | S賣出處分 | −15,467 | $20.43F2 | −$315,990.81 | 8,202,416 | 直接 | |
| 2021/12/7 | Class B Common Stock | S賣出處分 | −1,200 | $21.06F3 | −$25,272 | 8,201,216 | 直接 | |
| 2021/12/7 | Class B Common Stock | S賣出處分 | −3,025 | $20.49F4 | −$61,982.25 | 146,975 | 間接 | |
| 2021/12/7 | Class B Common Stock | S賣出處分 | −100 | $21.07 | −$2,107 | 146,875 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.01 to $20.99 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $21.02 to $21.11 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.07 to $21.06 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
表 I 有 1 筆交易的價格引用這則附註。